Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Levy Adam Scott
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Congleton Jon
Mineralys Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(6.4%),TCG Crossover Fund II, L.P.(6.4%), etc.
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director AKKARAJU SRINIVAS
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Samsara BioCapital GP, LLC
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director RA CAPITAL MANAGEMENT, L.P.
Mineralys Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Adams Street Partners, LLC(5.60%),Adams Street Growth Equity Fund VII LP(2.17%), etc.
Mineralys Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Catalys Pacific Fund, LP(22.4%),Catalys Pacific Fund GP, LP(22.4%), etc.
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom
Mineralys Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-HBM Healthcare Investments (Cayman) Ltd.(5.5%)
Mineralys Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%), etc.
Mineralys Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Samsara BioCapital, L.P.(10.3%),Samsara BioCapital GP, LLC(10.3%), etc.
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Congleton Jon
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom
Mineralys Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodman David Malcom
No Data